health
FDA Approves Diet Pill Like Ozempic: How Does It Work?
The U.S. Food and Drug Administration (FDA) authorized a new GLP-1-based pill for weight loss on Wednesday, expanding the available alternatives for obesity, a constantly growing disease.
TL;DR
- The FDA has approved Foundayo, a new oral GLP-1-based pill for weight loss developed by Eli Lilly.
- Foundayo offers greater flexibility than other GLP-1 options, as it can be taken at any time of day without dietary restrictions or fasting.
- This new pill is a potential alternative to injectable weight loss medications like Wegovy and Zepbound.
- Clinical trials showed an average weight loss of 12% over 72 weeks in participants taking the highest dose of Foundayo.
- The initial monthly cost for Foundayo starts at $149 for lower doses and can reach $349 for higher doses, with potential reductions for treatment renewal.
- Common side effects include nausea, constipation, and gastrointestinal discomfort.
- The medication is currently approved only for adults.